Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Inhibition of PKCα/β with ruboxistaurin antagonizes heart failure in pigs after myocardial infarction injury.

Ladage D, Tilemann L, Ishikawa K, Correll RN, Kawase Y, Houser SR, Molkentin JD, Hajjar RJ.

Circ Res. 2011 Dec 9;109(12):1396-400. doi: 10.1161/CIRCRESAHA.111.255687. Epub 2011 Oct 13.

PMID:
21998327
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition.

Tuttle KR, Anderson PW.

Am J Kidney Dis. 2003 Sep;42(3):456-65. Review.

PMID:
12955673
[PubMed - indexed for MEDLINE]
3.

Ruboxistaurin mesilate hydrate for diabetic retinopathy.

Schwartz SG, Flynn HW Jr, Aiello LP.

Drugs Today (Barc). 2009 Apr;45(4):269-74. doi: 10.1358/dot.2009.45.4.1354195. Review.

PMID:
19499092
[PubMed - indexed for MEDLINE]
4.

Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.

Joy SV, Scates AC, Bearelly S, Dar M, Taulien CA, Goebel JA, Cooney MJ.

Ann Pharmacother. 2005 Oct;39(10):1693-9. Epub 2005 Sep 13. Review.

PMID:
16160002
[PubMed - indexed for MEDLINE]
5.

Ruboxistaurin.

Taulien CA, Joy SV.

Drugs Today (Barc). 2006 Sep;42(9):577-85. Review.

PMID:
17028667
[PubMed - indexed for MEDLINE]
6.

[Protein kinase C beta-Inhibitor ruboxistaurin].

Musch A.

Med Monatsschr Pharm. 2005 Aug;28(8):292-3. Review. German. No abstract available.

PMID:
16128544
[PubMed - indexed for MEDLINE]
7.

Ruboxistaurin: LY 333531.

[No authors listed]

Drugs R D. 2007;8(3):193-9. Review.

PMID:
17472415
[PubMed - indexed for MEDLINE]
8.

Protein kinase Cα as a heart failure therapeutic target.

Liu Q, Molkentin JD.

J Mol Cell Cardiol. 2011 Oct;51(4):474-8. doi: 10.1016/j.yjmcc.2010.10.004. Epub 2010 Oct 16. Review.

PMID:
20937286
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk